Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 2 3Phase 4 1Phase 3 1Phase 1/2 1

Status

Completed 4Terminated 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1

Conditions

Solid Tumors 1Recurrence 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia, Myeloid, Acute 1Leukemia 1Advanced Solid Tumors 1

Interventions

pembrolizumab 304Paclitaxel 206Carboplatin 200Gemcitabine 173Cisplatin 139Docetaxel 138Cyclophosphamide 136Nivolumab 129Bevacizumab 118Injections 111fludarabine 96atezolizumab 91Pemetrexed 90Dexamethasone 90Cetuximab 90Fluorouracil 84Irinotecan 77Rituximab 72Capecitabine 72venetoclax 71Azacitidine 70130-nm albumin-bound paclitaxel 67Leucovorin 65Fulvestrant 58Oxaliplatin 57durvalumab 56Trastuzumab 56Lenalidomide 55Ipilimumab 55Midazolam 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × Dosage Forms × Clear all
NCT02939183 2024-09-26

INTREPID-1

Amgen

Phase 1 Completed
61 enrolled 28 charts
Plasma cell

Multiple Myeloma, Recurrence

NCT01784757 2021-03-17

ARAFOR

Orion Corporation, Orion Pharma

Phase 1 Completed
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT00632424 2016-03-10

Phase 1 Trial of Oral Ixabepilone

R-Pharm

Phase 1 Terminated
23 enrolled 11 charts
Other solid neoplasm

Advanced Solid Tumors

NCT00125827 2014-03-19

Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors

Sanofi

Phase 1 Completed
24 enrolled
Other solid neoplasm

Solid Tumors

NCT00125840 2014-02-05

Clofarabine in Adult Patients With Advanced Solid Tumors

Sanofi

Phase 1 Completed
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡